Anatoly B. Dobrovolsky

Anatoly B. Dobrovolsky

Auto-generated profile, based on publicly available information

Anatoly B. Dobrovolsky

Chazov National Medical Research Center of Cardiology

Research Focus & Metrics

Academic Career Length

43Years (1984-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2002 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
ADA. B. Dobrovolsky
A. B. Dobrovolsky
ETE. V. Titaeva
E. V. Titaeva

15 August 2002 in European Heart Journal
Verified
Journal Article
Open access
PDF file
AKA.L. Komarov
A.L. Komarov
EPE.P. Panchenko
E.P. Panchenko
ADA.B. Dobrovolsky
A.B. Dobrovolsky
YKYu.A. Karpov
Yu.A. Karpov
ADA.D. Deev
A.D. Deev
AEA.R. Eshkeeva
A.R. Eshkeeva
Aims To evaluate the frequency of arterial thrombotic events in patients with peripheral arterial occlusive disease during 3–5 years of follow-up and

1 February 2011 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
AMA. V. Mazurov
A. V. Mazurov
ETE. V. Titaeva
E. V. Titaeva
SKS. G. Khaspekova
S. G. Khaspekova
ASA. N. Storojilova
A. N. Storojilova
VSV. A. Spiridonova
V. A. Spiridonova
ADA. B. Dobrovolsky
A. B. Dobrovolsky

1 January 1995 in European Heart Journal
Verified
Journal Article
Closed access
PDF file
EPE. Panchenko
E. Panchenko
ADA. Dobrovolsky
A. Dobrovolsky
KDK. Davletov
K. Davletov
ETE. Titaeva
E. Titaeva
AKA. Kravets
A. Kravets
YKY. Karpov
Y. Karpov
D-dimer, plasminogen activator inhibitor (PAI-1) activity at rest and after exercise, and tissue plasminogen activator (t-PA) activity after exercise were measured in venous blood in 88 patients with atherosclerotic lesions of various degrees. According to clinical symptoms, coronary angiography (CAG), ultrasound Doppler signal and duplex and colour Doppler scanning of carotid arteries and their branches, subclavian, vertebral and peripheral arteries of the lower limbs, patients were divided into four groups. Group 1, 16 men without CAG and ultrasound signs of atherosclerotic lesions; group 2, 27 patients with CAG-confirmed coronary artery disease; group 3, 18 patients with peripheral artery occlusive disease; group 4, 27 patients with coexistence of two or more regions of atherosclerotic lesions. D-dimer was the highest in patients with the most extensive atherosclerosis: 432 ± 164 ng. ml−1 in group 3, 429 ±98 ng. ml−1 in group 4 vs 163 ±25 ng. ml−1 in group 1, P<0.05. There were correlations (P<0.05) between: age and D-dimer (r=0.29); D-dimer and t-PA (r=0.34); D-dimer and PAI-1, r= −0.29. Patients were also analysed according to D-dimer level. In patients with the highest level of D-dimer, the lowest level of PAI-1 activity and the highest level of t-PA activity after exercise were observed. The low PAI-1 activity is probably the result of an increased release of t-PA in these patients.

16 February 2016 in Biochemistry (Moscow)
Verified
Journal Article
Closed access
PDF file
SKS. G. Khaspekova
S. G. Khaspekova
OAO. A. Antonova
O. A. Antonova
OSO. N. Shustova
O. N. Shustova
VYV. V. Yakushkin
V. V. Yakushkin
NGN. V. Golubeva
N. V. Golubeva
AMAlexey Mazurov
Alexey Mazurov
Activity of tissue factor (TF) in membrane microparticles (MPs) produced in vitro by endothelial cells (ECs), monocytes, THP-1 monocytic cells, granulocytes, and platelets was investigated. ECs were isolated from human umbilical vein, and monocytes, granulocytes, and platelets - from the blood of healthy donors. ECs, monocytes, and THP-1 cells were activated by bacterial lipopolysaccharide, granulocytes - by lipopolysaccharide or phorbol myristate acetate, and platelets - by SFLLRN, thrombin receptor-activating peptide. MPs were sedimented from the culture medium or supernatant of activated cells at 20,000g for 30 min. Coagulation activity of MPs was analyzed in a modified recalcification assay by assessing their effects on coagulation of donor plasma depleted of endogenous MPs (by centrifuging at 20,000g for 90 min). MPs from all cell types accelerated plasma coagulation. Antibodies blocking TF activity prolonged coagulation lag-phase in the presence of MPs from ECs, monocytes, and THP-1 cells (by 2.7-, 2.0-, and 1.8-fold, respectively), but did not influence coagulation in the presence of MPs from granulocytes and platelets. In accordance with these data, TF activity measured by its ability to activate factor X was found in MPs from ECs, monocytes, and THP-1 cells, but not in MPs from granulocytes and platelets. The data obtained indicate that active TF is present in MPs produced in vitro by ECs, monocytes, and THP-1 cells, but not in MPs derived from granulocytes and platelets.

1 July 2009 in Bulletin of Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDF file
ADA. B. Dobrovolsky
A. B. Dobrovolsky
ETE. V. Titaeva
E. V. Titaeva
SKS. G. Khaspekova
S. G. Khaspekova
VSV. A. Spiridonova
V. A. Spiridonova
AKA. M. Kopylov
A. M. Kopylov
AMA. V. Mazurov
A. V. Mazurov